Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Jun;25(6):625-634.
doi: 10.1097/GME.0000000000001062.

Hormone therapy and urine protein excretion: a multiracial cohort study, systematic review, and meta-analysis

Andrea G Kattah  1 , Maria L G Suarez  1 , Natasa Milic  2 , Kejal Kantarci  3 , Burcu Zeydan  3 , Thomas Mosley  4 , Stephen T Turner  1 , Erin B Ware  5   6 , Sharon L R Kardia  5 , Vesna D Garovic  1
Affiliations
Meta-Analysis

Hormone therapy and urine protein excretion: a multiracial cohort study, systematic review, and meta-analysis

Andrea G Kattah et al. Menopause. 2018 Jun.

Abstract

Objective: Experimental models suggest estrogen has a renoprotective effect, but human studies show variable results. Our objective was to study the association of hormone therapy (HT) and albuminuria in postmenopausal women and to synthesize the results with outcomes from prior studies.

Methods: We analyzed data from postmenopausal women who participated in the second study visit (2000-2004) of the Genetic Epidemiology Network of Arteriopathy (GENOA) study. The exposure was self-reported HT use and the outcome was albuminuria (urine albumin-to-creatinine ratio >25 mg/g creatinine). We also conducted a systematic review and meta-analysis on the association of HT and urine protein in postmenopausal women. Continuous and dichotomous measures of protein excretion were converted to a standardized mean difference (SMD) for each study.

Results: In the GENOA cohort (n = 2,217), there were fewer women with albuminuria among HT users than nonusers (9% vs 19%, P < 0.001). HT use was associated with decreased odds of albuminuria (odds ratio 0.65, 95% confidence interval (CI), 0.45-0.95), after adjusting for significant differences in age, race, education, comorbidities, and the age at and cause of menopause. The SMD of the effect of HT on urine proteinuria/albuminuria in the randomized control trials (n = 3) was 0.02 (95% CI, -0.29 to 0.33) and -0.13 (95% CI, -0.31 to 0.05) in the observational studies (n = 9). There was significantly less albuminuria among HT users (SMD -0.15, 95% CI, -0.27 to -0.04) in the 9 studies that only reported albuminuria as an outcome and in the 10 studies with a comparator arm (SMD -0.15, 95% CI, -0.26 to -0.04).

Conclusions: HT is associated with decreased odds of albuminuria, but some of the observed benefits may be related to reported outcomes, the presence of a comparator arm, and the type of study design.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram outlining the identification of studies included in the systematic review and meta-analysis. HT = Hormone Therapy.
Figure 2
Figure 2
Forest Plot of the standardized mean difference of the effect of hormone therapy on urine albuminuria/proteinuria in observational studies and randomized controlled trials. Each study is listed according to subgroup, with the corresponding weight, standardized mean difference and 95% Confidence Interval (CI).
Figure 3
Figure 3
Forest Plot of the standardized mean difference of the effect of hormone therapy on urine albuminuria and proteinuria in all included studies. Each study is listed according to subgroup, with the corresponding weight, standardized mean difference and 95% Confidence Interval (CI).
See this image and copyright information in PMC

Comment in

References

    1. Berg UB. Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2006;21(9):2577–82. - PubMed
    1. Coggins CH, Breyer Lewis J, Caggiula AW, Castaldo LS, Klahr S, Wang SR. Differences between women and men with chronic renal disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 1998;13(6):1430–7. - PubMed
    1. Neugarten J, Acharya A, Lei J, Silbiger S. Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. Am J Physiol Renal Physiol. 2000;279(2):F309–18. - PubMed
    1. Xu R, Zhang LX, Zhang PH, Wang F, Zuo L, Wang HY. Gender differences in age-related decline in glomerular filtration rates in healthy people and chronic kidney disease patients. BMC Nephrol. 2010;11:20. - PMC - PubMed
    1. Kummer S, von Gersdorff G, Kemper MJ, Oh J. The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease. Pediatr Nephrol. 2012;27(8):1213–9. - PubMed

Publication types